{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:34:37Z","timestamp":1793082877998,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["CA291724"],"award-info":[{"award-number":["CA291724"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["CA233576"],"award-info":[{"award-number":["CA233576"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.celrep.2026.117551","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:55:19Z","timestamp":1781628919000},"page":"117551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Constraining regulatory domain dynamics of the Src kinase Fgr increases ATP-site inhibitor sensitivity and impairs bone marrow engraftment"],"prefix":"10.1016","volume":"45","author":[{"given":"Giancarlo","family":"Gonzalez-Areizaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry T.","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5238-3806","authenticated-orcid":false,"given":"Thomas E.","family":"Smithgall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2026.117551_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089560","article-title":"Activating FLT3 mutants show distinct gain-of-function phenotypes in vitro and a characteristic signaling pathway profile associated with prognosis in acute myeloid leukemia","volume":"9","author":"Janke","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2026.117551_bib2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s11899-014-0203-8","article-title":"FLT3 inhibitors in AML: are we there yet? Curr","volume":"9","author":"Sudhindra","year":"2014","journal-title":"Hematol. Malig. Rep"},{"key":"10.1016\/j.celrep.2026.117551_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.critrevonc.2019.06.011","article-title":"Clinical considerations for the use of FLT3 inhibitors in acute myeloid leukemia","volume":"141","author":"Weis","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.celrep.2026.117551_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225887","article-title":"Expression of myeloid Src-family kinases is associated with poor prognosis in AML and influences Flt3-ITD kinase inhibitor acquired resistance","volume":"14","author":"Patel","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2026.117551_bib5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbapap.2005.07.027","article-title":"Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases","volume":"1754","author":"Chong","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.celrep.2026.117551_bib6","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1038\/s41388-022-02231-y","article-title":"Correction to: Regulation of Src tumor activity by its N-terminal intrinsically disordered region","volume":"41","author":"Aponte","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2026.117551_bib7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/385595a0","article-title":"Three-dimensional structure of the tyrosine kinase c-Src","volume":"385","author":"Xu","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117551_bib8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1097-2765(00)80356-1","article-title":"Crystal structures of c-Src reveal features of its autoinhibitory mechanism","volume":"3","author":"Xu","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2026.117551_bib9","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/385602a0","article-title":"Crystal structure of the Src family tyrosine kinase Hck","volume":"385","author":"Sicheri","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117551_bib10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S1097-2765(00)80357-3","article-title":"Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor","volume":"3","author":"Schindler","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2026.117551_bib11","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1021\/acs.biochem.4c00323","article-title":"Cocrystallization of the Src-Family Kinase Hck with the ATP-Site Inhibitor A-419259 Stabilizes an Extended Activation Loop Conformation","volume":"63","author":"Selzer","year":"2024","journal-title":"Biochemistry"},{"key":"10.1016\/j.celrep.2026.117551_bib12","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.str.2022.08.008","article-title":"ATP-site inhibitors induce unique conformations of the acute myeloid leukemia-associated Src-family kinase","volume":"30","author":"Du","year":"2022","journal-title":"Fgr. Structure"},{"key":"10.1016\/j.celrep.2026.117551_bib13","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1007\/s00018-008-8122-2","article-title":"Structure and dynamic regulation of Src-family kinases","volume":"65","author":"Engen","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.celrep.2026.117551_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aat5916","article-title":"The Src family kinase Fgr is a transforming oncoprotein that functions independently of SH3-SH2 domain regulation","volume":"11","author":"Shen","year":"2018","journal-title":"Sci. Signal."},{"key":"10.1016\/j.celrep.2026.117551_bib15","doi-asserted-by":"crossref","first-page":"181ra152","DOI":"10.1126\/scitranslmed.3004387","article-title":"A pyrrolo-pyrimidine derivative targets human primary AML stem cells in vivo","volume":"5","author":"Saito","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2026.117551_bib16","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1021\/acschembio.8b00154","article-title":"Selective inhibition of the myeloid Src-family kinase Fgr potently suppresses AML cell growth in vitro and in vivo","volume":"13","author":"Weir","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.celrep.2026.117551_bib17","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nchembio.1938","article-title":"The ins and outs of selective kinase inhibitor development","volume":"11","author":"M\u00fcller","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.celrep.2026.117551_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105629","article-title":"Differential sensitivity of Src-family kinases to activation by SH3 domain displacement","volume":"9","author":"Moroco","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2026.117551_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.108088","article-title":"An SH3-binding allosteric modulator stabilizes the global conformation of the AML-associated Src-family kinase","volume":"301","author":"Selzer","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.celrep.2026.117551_bib20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41598-024-83740-6","article-title":"Constitutive activation of the Src-family kinases Fgr and Hck enhances the tumor burden of acute myeloid leukemia cells in immunocompromised mice","volume":"15","author":"Shu","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2026.117551_bib21","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1074\/jbc.R112.438382","article-title":"Structure and dynamic regulation of Abl kinases","volume":"288","author":"Panjarian","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.celrep.2026.117551_bib22","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1074\/jbc.M112.431312","article-title":"Enhanced SH3\/linker interaction overcomes Abl kinase activation by gatekeeper and myristic acid binding pocket mutations and increases sensitivity to small molecule inhibitors","volume":"288","author":"Panjarian","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.celrep.2026.117551_bib23","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nature21702","article-title":"The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1","volume":"543","author":"Wylie","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117551_bib24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ccell.2019.08.004","article-title":"Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants","volume":"36","author":"Eide","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117551_bib25","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.ccell.2024.08.004","article-title":"Overcoming clinical BCR-ABL1 compound mutant resistance with combined ponatinib and asciminib therapy","volume":"42","author":"Eide","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117551_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/science.adw8310","article-title":"Conformational landscape adaptations enable processive phosphorylation by Src family kinases","volume":"390","author":"Cui","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117551_bib27","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nsmb.3470","article-title":"Atomic view of the energy landscape in the allosteric regulation of Abl kinase","volume":"24","author":"Saleh","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.celrep.2026.117551_bib28","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3389\/fchem.2019.00822","article-title":"Discovery of Non-peptide Small Molecule Allosteric Modulators of the Src-family Kinase, Hck","volume":"7","author":"Dorman","year":"2019","journal-title":"Front. Chem."},{"key":"10.1016\/j.celrep.2026.117551_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181178","article-title":"Dual inhibition of Fes and Flt3 tyrosine kinases potently inhibits Flt3-ITD+ AML cell growth","volume":"12","author":"Weir","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2026.117551_bib30","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ccr.2014.01.022","article-title":"SYK is a critical regulator of FLT3 in acute myeloid leukemia","volume":"25","author":"Puissant","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117551_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.111099","article-title":"Chaperone-assisted expression and purification of the AML-associated Src-family kinase Fgr in E. coli","volume":"302","author":"Gonzalez-Areizaga","year":"2026","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.celrep.2026.117551_bib32","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1177\/1087057106286829","article-title":"A generic, homogenous method for measuring kinase and inhibitor activity via adenosine 5'-diphosphate accumulation","volume":"11","author":"Charter","year":"2006","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.celrep.2026.117551_bib33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"Xds","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.celrep.2026.117551_bib34","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1107\/S0907444913000061","article-title":"How good are my data and what is the resolution?","volume":"69","author":"Evans","year":"2013","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.celrep.2026.117551_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1107\/S2059798317017235","article-title":"DIALS: implementation and evaluation of a new integration package","volume":"74","author":"Winter","year":"2018","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.celrep.2026.117551_bib36","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.celrep.2026.117551_bib37","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1107\/S0907444996012255","article-title":"Refinement of macromolecular structures by the maximum-likelihood method","volume":"53","author":"Murshudov","year":"1997","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.celrep.2026.117551_bib38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.celrep.2026.117551_bib39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1107\/S0907444911001314","article-title":"REFMAC5 for the refinement of macromolecular crystal structures","volume":"67","author":"Murshudov","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.celrep.2026.117551_bib40","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.celrep.2026.117551_bib41","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix","volume":"75","author":"Liebschner","year":"2019","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.celrep.2026.117551_bib42","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1107\/S2059798323003595","article-title":"The CCP4 suite: integrative software for macromolecular crystallography","volume":"79","author":"Agirre","year":"2023","journal-title":"Acta Crystallogr. D Struct. Biol."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726006297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726006297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:52:18Z","timestamp":1793080338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124726006297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2211124726006297"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117551","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Constraining regulatory domain dynamics of the Src kinase Fgr increases ATP-site inhibitor sensitivity and impairs bone marrow engraftment","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117551"}}